Persistence of immune responses to the HPV-16/18 AS04-adjuvanted vaccine in women aged 15–55 years and first-time modelling of antibody responses in mature women: results from an open-label 6–year follow-up study

OBJECTIVE: Evaluation of the long-term HPV-16/18 AS04-adjuvanted vaccine immunogenicity persistence in women. DESIGN: Multicentre, open-label, long-term follow-up (NCT00947115) of a primary phase–III study (NCT00196937). SETTING: Six centres in Germany and Poland. POPULATION: 488 healthy women (aged...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwarz, T, Spaczynski, M, Kaufmann, A, Wysocki, J, Gałaj, A, Schulze, K, Suryakiran, P, Thomas, F, Descamps, D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Gynaecological Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489326/
https://www.ncbi.nlm.nih.gov/pubmed/25208608
http://dx.doi.org/10.1111/1471-0528.13070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489326/
https://www.ncbi.nlm.nih.gov/pubmed/25208608
http://dx.doi.org/10.1111/1471-0528.13070

Ejemplares similares